Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
At StockStory, we look beyond the headlines with our independent analysis to determine whether these bearish calls are justified. That said, here are three stocks where the outlook is warranted and some alternatives with better fundamentals.
Okta (OKTA)
Consensus Price Target: $124.74 (-16.5% implied return)
Named after the meteorological measurement for cloud cover, Okta (NASDAQ: OKTA) provides cloud-based identity management solutions that help organizations securely connect their employees, partners, and customers to the right applications and services.
Why Do We Think Twice About OKTA?
- Products, pricing, or go-to-market strategy may need some adjustments as its 10.8% average billings growth over the last year was weak
- Estimated sales growth of 9.1% for the next 12 months implies demand will slow from its two-year trend
- Operating margin improvement of 5.1 percentage points over the last year demonstrates its ability to scale efficiently
Okta is trading at $149.35 per share, or 8.1x forward price-to-sales. If you’re considering OKTA for your portfolio, see our FREE research report to learn more.
United Parcel Service (UPS)
Consensus Price Target: $114.69 (1.3% implied return)
Trademarking its recognizable UPS Brown color, UPS (NYSE: UPS) offers package delivery, supply chain management, and freight forwarding services.
Why Should You Dump UPS?
- Sales stagnated over the last five years and signal the need for new growth strategies
- Free cash flow margin shrank by 6.1 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive
- Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
United Parcel Service’s stock price of $113.25 implies a valuation ratio of 15.6x forward P/E. Read our free research report to see why you should think twice about including UPS in your portfolio.
Chemed (CHE)
Consensus Price Target: $474 (-7.7% implied return)
With a unique business model combining end-of-life care and household services, Chemed (NYSE: CHE) operates two distinct businesses: VITAS, which provides hospice care for terminally ill patients, and Roto-Rooter, which offers plumbing and water restoration services.
Why Are We Hesitant About CHE?
- Annual revenue growth of 4% over the last five years was below our standards for the healthcare sector
- Earnings growth underperformed the sector average over the last five years as its EPS grew by just 2.8% annually
- Waning returns on capital imply its previous profit engines are losing steam
At $513.71 per share, Chemed trades at 20.5x forward P/E. To fully understand why you should be careful with CHE, check out our full research report (it’s free).
Stocks We Like More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
